Future treatments may increasingly integrate GLP-1 with other therapies for a holistic approach
Multiple peptides that strongly stimulate the same pathway could cause overstimulation
8.5 Geriatric Use In the pool of placebo- and active-controlled glycemic control trials, 744 (23.6%) OZEMPIC-treated patients were 65 years of age and over and 102 OZEMPIC-treated patients (3.2%) patients were 75 years of age and over
The study population had a mean age of 54 years and a mean BMI of 36.1 kg/m 2 and experienced a BW reduction of 12.8%, 14.7% and 3.2% with tirzepatide 10 mg, tirzepatide 15 mg and placebo, respectively, at 72 weeks 37
Autoimmune diseases develop when the immune system, which is meant to defend the body from infections, mistakenly targets healthy cells and tissues
It just doesnt work as well as I hoped This definitely works